Resveratrol and its analogs as antitumoral agents for breast cancer treatment

Adele Chimento, Rosa Sirianni, Carmela Saturnino, Anna Caruso, Maria Stefania Sinicropi, Vincenzo Pezzi

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Resveratrol (3,5,4’-tri-hydroxystilbene) (RSV), a naturally occurring phytoalexin, readily available in the diet, has gained interest as a non-toxic agent capable of displaying cancer-preventing and anti-cancer properties. Several studies, using both in vitro and in vivo models, have illustrated RSV capacity to modulate a multitude of signaling pathways associated with cellular growth and division, apoptosis, angiogenesis, invasion and metastasis. However, its clinical application is limited because of a low oral bioavailability with high adsorption but rapid metabolism and low tissue concentrations. Several chemical modifications to the backbone structure have been made for the purpose of improving pharmacokinetic parameters. One promising strategy involves the introduction of methoxylic or hydroxylic groups on the phenylic rings of RSV. Moreover, by replacing the alkene linker between the two aromatic rings with a heterocyclic system rigid analogs such as 2,3-thiazolidin-4-ones and 3-chloro-azetidin-2-ones that displayed higher cytotoxic activity and hence higher ability to inhibit in vitro breast cancer cell growth have been synthesized. In vitro studies have demonstrated, for some of these compounds, a greater bioaccessibility than RSV and more selective inhibitory effects on breast cancer cell growth. Further investigations, particularly in vivo, are required as next step to implicate these analogs as pharmacologic agents for a possible clinical anticancer application.

Original languageEnglish (US)
Pages (from-to)699-709
Number of pages11
JournalMini-Reviews in Medicinal Chemistry
Volume16
Issue number9
StatePublished - Jun 1 2016

Fingerprint

Breast Neoplasms
Growth
Alkenes
Biological Availability
Adsorption
Neoplasms
Pharmacokinetics
Apoptosis
Neoplasm Metastasis
Diet
In Vitro Techniques
resveratrol
phytoalexins
4-hydroxystilbene

Keywords

  • Analogs
  • Antitumoral Agents
  • Breast Cancer
  • Cell Growth Inhibition
  • RSV
  • RSV Bioaccessibility

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Cite this

Chimento, A., Sirianni, R., Saturnino, C., Caruso, A., Sinicropi, M. S., & Pezzi, V. (2016). Resveratrol and its analogs as antitumoral agents for breast cancer treatment. Mini-Reviews in Medicinal Chemistry, 16(9), 699-709.

Resveratrol and its analogs as antitumoral agents for breast cancer treatment. / Chimento, Adele; Sirianni, Rosa; Saturnino, Carmela; Caruso, Anna; Sinicropi, Maria Stefania; Pezzi, Vincenzo.

In: Mini-Reviews in Medicinal Chemistry, Vol. 16, No. 9, 01.06.2016, p. 699-709.

Research output: Contribution to journalArticle

Chimento, A, Sirianni, R, Saturnino, C, Caruso, A, Sinicropi, MS & Pezzi, V 2016, 'Resveratrol and its analogs as antitumoral agents for breast cancer treatment', Mini-Reviews in Medicinal Chemistry, vol. 16, no. 9, pp. 699-709.
Chimento A, Sirianni R, Saturnino C, Caruso A, Sinicropi MS, Pezzi V. Resveratrol and its analogs as antitumoral agents for breast cancer treatment. Mini-Reviews in Medicinal Chemistry. 2016 Jun 1;16(9):699-709.
Chimento, Adele ; Sirianni, Rosa ; Saturnino, Carmela ; Caruso, Anna ; Sinicropi, Maria Stefania ; Pezzi, Vincenzo. / Resveratrol and its analogs as antitumoral agents for breast cancer treatment. In: Mini-Reviews in Medicinal Chemistry. 2016 ; Vol. 16, No. 9. pp. 699-709.
@article{f672a7d4581844788643935afc265c8e,
title = "Resveratrol and its analogs as antitumoral agents for breast cancer treatment",
abstract = "Resveratrol (3,5,4’-tri-hydroxystilbene) (RSV), a naturally occurring phytoalexin, readily available in the diet, has gained interest as a non-toxic agent capable of displaying cancer-preventing and anti-cancer properties. Several studies, using both in vitro and in vivo models, have illustrated RSV capacity to modulate a multitude of signaling pathways associated with cellular growth and division, apoptosis, angiogenesis, invasion and metastasis. However, its clinical application is limited because of a low oral bioavailability with high adsorption but rapid metabolism and low tissue concentrations. Several chemical modifications to the backbone structure have been made for the purpose of improving pharmacokinetic parameters. One promising strategy involves the introduction of methoxylic or hydroxylic groups on the phenylic rings of RSV. Moreover, by replacing the alkene linker between the two aromatic rings with a heterocyclic system rigid analogs such as 2,3-thiazolidin-4-ones and 3-chloro-azetidin-2-ones that displayed higher cytotoxic activity and hence higher ability to inhibit in vitro breast cancer cell growth have been synthesized. In vitro studies have demonstrated, for some of these compounds, a greater bioaccessibility than RSV and more selective inhibitory effects on breast cancer cell growth. Further investigations, particularly in vivo, are required as next step to implicate these analogs as pharmacologic agents for a possible clinical anticancer application.",
keywords = "Analogs, Antitumoral Agents, Breast Cancer, Cell Growth Inhibition, RSV, RSV Bioaccessibility",
author = "Adele Chimento and Rosa Sirianni and Carmela Saturnino and Anna Caruso and Sinicropi, {Maria Stefania} and Vincenzo Pezzi",
year = "2016",
month = "6",
day = "1",
language = "English (US)",
volume = "16",
pages = "699--709",
journal = "Mini-Reviews in Medicinal Chemistry",
issn = "1389-5575",
publisher = "Bentham Science Publishers B.V.",
number = "9",

}

TY - JOUR

T1 - Resveratrol and its analogs as antitumoral agents for breast cancer treatment

AU - Chimento, Adele

AU - Sirianni, Rosa

AU - Saturnino, Carmela

AU - Caruso, Anna

AU - Sinicropi, Maria Stefania

AU - Pezzi, Vincenzo

PY - 2016/6/1

Y1 - 2016/6/1

N2 - Resveratrol (3,5,4’-tri-hydroxystilbene) (RSV), a naturally occurring phytoalexin, readily available in the diet, has gained interest as a non-toxic agent capable of displaying cancer-preventing and anti-cancer properties. Several studies, using both in vitro and in vivo models, have illustrated RSV capacity to modulate a multitude of signaling pathways associated with cellular growth and division, apoptosis, angiogenesis, invasion and metastasis. However, its clinical application is limited because of a low oral bioavailability with high adsorption but rapid metabolism and low tissue concentrations. Several chemical modifications to the backbone structure have been made for the purpose of improving pharmacokinetic parameters. One promising strategy involves the introduction of methoxylic or hydroxylic groups on the phenylic rings of RSV. Moreover, by replacing the alkene linker between the two aromatic rings with a heterocyclic system rigid analogs such as 2,3-thiazolidin-4-ones and 3-chloro-azetidin-2-ones that displayed higher cytotoxic activity and hence higher ability to inhibit in vitro breast cancer cell growth have been synthesized. In vitro studies have demonstrated, for some of these compounds, a greater bioaccessibility than RSV and more selective inhibitory effects on breast cancer cell growth. Further investigations, particularly in vivo, are required as next step to implicate these analogs as pharmacologic agents for a possible clinical anticancer application.

AB - Resveratrol (3,5,4’-tri-hydroxystilbene) (RSV), a naturally occurring phytoalexin, readily available in the diet, has gained interest as a non-toxic agent capable of displaying cancer-preventing and anti-cancer properties. Several studies, using both in vitro and in vivo models, have illustrated RSV capacity to modulate a multitude of signaling pathways associated with cellular growth and division, apoptosis, angiogenesis, invasion and metastasis. However, its clinical application is limited because of a low oral bioavailability with high adsorption but rapid metabolism and low tissue concentrations. Several chemical modifications to the backbone structure have been made for the purpose of improving pharmacokinetic parameters. One promising strategy involves the introduction of methoxylic or hydroxylic groups on the phenylic rings of RSV. Moreover, by replacing the alkene linker between the two aromatic rings with a heterocyclic system rigid analogs such as 2,3-thiazolidin-4-ones and 3-chloro-azetidin-2-ones that displayed higher cytotoxic activity and hence higher ability to inhibit in vitro breast cancer cell growth have been synthesized. In vitro studies have demonstrated, for some of these compounds, a greater bioaccessibility than RSV and more selective inhibitory effects on breast cancer cell growth. Further investigations, particularly in vivo, are required as next step to implicate these analogs as pharmacologic agents for a possible clinical anticancer application.

KW - Analogs

KW - Antitumoral Agents

KW - Breast Cancer

KW - Cell Growth Inhibition

KW - RSV

KW - RSV Bioaccessibility

UR - http://www.scopus.com/inward/record.url?scp=84964290937&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964290937&partnerID=8YFLogxK

M3 - Article

VL - 16

SP - 699

EP - 709

JO - Mini-Reviews in Medicinal Chemistry

JF - Mini-Reviews in Medicinal Chemistry

SN - 1389-5575

IS - 9

ER -